Omixon Launches NanoTYPETM RUO, a Multiplex Human Leukocyte Antigen Amplification kit compatible with Oxford Nanopore’s MinIONTM Platform and Enters into an Agreement with Oxford Nanopore Technologies
High resolution histocompatibility testing for urgent transplant cases made possible within five hours turnaround time. Budapest, Hungary, September 27, 2022. Omixon Biocomputing, Ltd announced today the launch of NanoTYPETM RUO, a multiplex 11 loci human leukocyte antigen (HLA) amplification kit and the complementary NanoTYPERTM software compatible with Oxford Nanopore’s...